Kyle D Checchi1, Krista F Huybrechts1, Jerry Avorn1, Aaron S Kesselheim1. 1. Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Abstract
IMPORTANCE: Medication nonadherence, which has been estimated to affect 28% to 31% of US patients with hypertension, hyperlipidemia, and diabetes, may be improved by electronic medication packaging (EMP) devices (adherence-monitoring devices incorporated into the packaging of a prescription medication). OBJECTIVES: To investigate whether EMP devices are associated with improved adherence and to identify and describe common features of EMP devices. EVIDENCE REVIEW: Systematic review of peer-reviewed studies testing the effectiveness of EMP systems in the MEDLINE, EMBASE, PsycINFO, CINAHL, International Pharmaceutical Abstracts, and Sociological Abstracts databases from searches conducted to June 13, 2014, with extraction of associations between the interventions and adherence, as well as other key findings. Each study was assessed for bias using the Cochrane Handbook for Systematic Reviews of Interventions; features of EMP devices and interventions were qualitatively assessed. FINDINGS: Thirty-seven studies (32 randomized and 5 nonrandomized) including 4326 patients met inclusion criteria (10 patient interface-only "simple" interventions and 29 "complex" interventions integrated into the health care system [2 qualified for both categories]). Overall, the effect estimates for differences in mean adherence ranged from a decrease of 2.9% to an increase of 34.0%, and the those for differences in the proportion of patients defined as adherent ranged from a decrease of 8.0% to an increase of 49.5%. We identified 5 common EMP characteristics: recorded dosing events and stored records of adherence, audiovisual reminders to cue dosing, digital displays, real-time monitoring, and feedback on adherence performance. CONCLUSIONS AND RELEVANCE: Many varieties of EMP devices exist. However, data supporting their use are limited, with variability in the quality of studies testing EMP devices. Devices integrated into the care delivery system and designed to record dosing events are most frequently associated with improved adherence, compared with other devices. Higher-quality evidence is needed to determine the effect, if any, of these low-cost interventions on medication nonadherence and to identify their most useful components.
IMPORTANCE: Medication nonadherence, which has been estimated to affect 28% to 31% of US patients with hypertension, hyperlipidemia, and diabetes, may be improved by electronic medication packaging (EMP) devices (adherence-monitoring devices incorporated into the packaging of a prescription medication). OBJECTIVES: To investigate whether EMP devices are associated with improved adherence and to identify and describe common features of EMP devices. EVIDENCE REVIEW: Systematic review of peer-reviewed studies testing the effectiveness of EMP systems in the MEDLINE, EMBASE, PsycINFO, CINAHL, International Pharmaceutical Abstracts, and Sociological Abstracts databases from searches conducted to June 13, 2014, with extraction of associations between the interventions and adherence, as well as other key findings. Each study was assessed for bias using the Cochrane Handbook for Systematic Reviews of Interventions; features of EMP devices and interventions were qualitatively assessed. FINDINGS: Thirty-seven studies (32 randomized and 5 nonrandomized) including 4326 patients met inclusion criteria (10 patient interface-only "simple" interventions and 29 "complex" interventions integrated into the health care system [2 qualified for both categories]). Overall, the effect estimates for differences in mean adherence ranged from a decrease of 2.9% to an increase of 34.0%, and the those for differences in the proportion of patients defined as adherent ranged from a decrease of 8.0% to an increase of 49.5%. We identified 5 common EMP characteristics: recorded dosing events and stored records of adherence, audiovisual reminders to cue dosing, digital displays, real-time monitoring, and feedback on adherence performance. CONCLUSIONS AND RELEVANCE: Many varieties of EMP devices exist. However, data supporting their use are limited, with variability in the quality of studies testing EMP devices. Devices integrated into the care delivery system and designed to record dosing events are most frequently associated with improved adherence, compared with other devices. Higher-quality evidence is needed to determine the effect, if any, of these low-cost interventions on medication nonadherence and to identify their most useful components.
Authors: Hein A W van Onzenoort; Willem J Verberk; Abraham A Kroon; Alfons G H Kessels; Cees Neef; Paul-Hugo M van der Kuy; Peter W de Leeuw Journal: Am J Hypertens Date: 2011-10-13 Impact factor: 2.689
Authors: Ashna D K Bowry; William H Shrank; Joy L Lee; Margaret Stedman; Niteesh K Choudhry Journal: J Gen Intern Med Date: 2011-08-20 Impact factor: 5.128
Authors: Alexander S Misono; Sarah L Cutrona; Niteesh K Choudhry; Michael A Fischer; Margaret R Stedman; Joshua N Liberman; Troyen A Brennan; Sachin H Jain; William H Shrank Journal: Am J Manag Care Date: 2010-12 Impact factor: 2.229
Authors: Faustinus Onyirimba; Andrea Apter; Susan Reisine; Mark Litt; Corliss McCusker; MaryLou Connors; Richard ZuWallack Journal: Ann Allergy Asthma Immunol Date: 2003-04 Impact factor: 6.347
Authors: Allison P Pack; Carol E Golin; Lauren M Hill; Jessica Carda-Auten; Deshira D Wallace; Sruthi Cherkur; Claire E Farel; Elias P Rosen; Monica Gandhi; Heather M Asher Prince; Angela D M Kashuba Journal: Patient Educ Couns Date: 2019-01-02
Authors: Jessica K Stevenson; Zoe C Campbell; Angela C Webster; Clara K Chow; Allison Tong; Jonathan C Craig; Katrina L Campbell; Vincent Ws Lee Journal: Cochrane Database Syst Rev Date: 2019-08-06
Authors: Tanya R Schlam; Jessica W Cook; Timothy B Baker; Todd Hayes-Birchler; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Megan E Piper Journal: Psychopharmacology (Berl) Date: 2018-04-25 Impact factor: 4.530
Authors: Kenneth H Mayer; Steven A Safren; Steven A Elsesser; Christina Psaros; Jake P Tinsley; Mark Marzinke; William Clarke; Craig Hendrix; S Wade Taylor; Jessica Haberer; Matthew J Mimiaga Journal: AIDS Behav Date: 2017-05